| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/11/2003 | US20030170841 Novel molecules of the pyrin domain protein family and uses thereof |
| 09/11/2003 | US20030170840 Genomic mammary amyloid a sequence |
| 09/11/2003 | US20030170839 Type 2 cytokine receptor and nucleic acids encoding same |
| 09/11/2003 | US20030170838 Novel polynucleotides and polypeptides encoded thereby |
| 09/11/2003 | US20030170835 Esterase, its DNA, its overexpression and production of optically active aryl propionic acids using the same |
| 09/11/2003 | US20030170834 Fungi/bacteria convert cinnamate/glucose/tyrosine to para-hydroxycinnamic acid via phenylalanine ammonia-lyase (PAL)/tyrosine ammonia-lyase |
| 09/11/2003 | US20030170833 Prenyltransferases; soybean proteins; improving plant growth |
| 09/11/2003 | US20030170826 Fusion proteins include cell penetrating domain linked to transmembrane domain |
| 09/11/2003 | US20030170825 Comprises antihemophilic factor (factor VIII) and antitrypsin signal sequences; for treatment of hemophilia |
| 09/11/2003 | US20030170821 DNA encoding B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells |
| 09/11/2003 | US20030170820 Mutation, synthesis and selection of a protein by incubating RNA with ribonucleoside triphosphate and polymerase; linked via ribosomes; translation |
| 09/11/2003 | US20030170819 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/11/2003 | US20030170812 Interleukin-1beta converting enzyme like cysteine protease |
| 09/11/2003 | US20030170811 Culturing a microorganism transformed with an expression vector comprising a gene encoding an amino acid sequence of a peptide-fused atriopeptin; use as antihypertensive diuretic agent |
| 09/11/2003 | US20030170808 Polypeptide encoded by polynucleotide of given sequence; use in diagnosis and treatment of various diseases |
| 09/11/2003 | US20030170792 MAGE-3 peptides presented by HLA class ll molecules |
| 09/11/2003 | US20030170790 Of given amino acid sequence; use in modulating cell activity, stimulating release of tumor necrosis factor, proteoglycans and cytokines; detecting tumors |
| 09/11/2003 | US20030170789 Of given amino acid sequence; use in modulating cell activity, stimulating release of tumor necrosis factor, proteoglycans and cytokines; detecting tumors |
| 09/11/2003 | US20030170788 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/11/2003 | US20030170787 Isolated nucleic acid; insecticides |
| 09/11/2003 | US20030170785 CDNA encoding the human alpha2 delta4 calcium channel subunit |
| 09/11/2003 | US20030170783 Method to extend the life span of normal cells |
| 09/11/2003 | US20030170782 Proteins |
| 09/11/2003 | US20030170779 Novel G protein-coupled receptors |
| 09/11/2003 | US20030170776 Antiinflammatory agents; kidney diseases; anticancer agents |
| 09/11/2003 | US20030170775 Prevention reproduction; genetic engineering |
| 09/11/2003 | US20030170770 Enzyme activation protease assay |
| 09/11/2003 | US20030170763 Protein antiallergens |
| 09/11/2003 | US20030170754 Anticancer agents; diagnosis of prostate cancer |
| 09/11/2003 | US20030170753 Artificial antibody polypeptides |
| 09/11/2003 | US20030170749 Detection using antibodies; parasiticides; veterinary medicine |
| 09/11/2003 | US20030170748 Compositions and methods for increasing amino acid absorption in mammals |
| 09/11/2003 | US20030170746 Method for screening an agent for ability to inhibit heparanase activity |
| 09/11/2003 | US20030170739 Polynucleotide sequence using markers |
| 09/11/2003 | US20030170736 Adjustment of cell differentiation; medical diagnosis |
| 09/11/2003 | US20030170730 Testing for drug desistance of cancer drugs |
| 09/11/2003 | US20030170727 Drug screening; cental nervous system disorders |
| 09/11/2003 | US20030170726 Stimulant or blocking protein cytoskeletons; anticancer agents, parasiticides |
| 09/11/2003 | US20030170725 Modulation of polyketide synthase gene modules; anticancer agents, fungicide, bactericide |
| 09/11/2003 | US20030170716 Detection of a polyhydroxyalkanoate synthease gene |
| 09/11/2003 | US20030170714 Polypeptides; activation lymphocytes |
| 09/11/2003 | US20030170711 Adjustment genotype; detecting polymorphism; diagnosis of genetic disorders |
| 09/11/2003 | US20030170709 Method of examining foreign matter derived from living body |
| 09/11/2003 | US20030170708 Screening for mutants; primer amplification |
| 09/11/2003 | US20030170705 Hybridization Dna; immobilization; testing |
| 09/11/2003 | US20030170704 Therapy for central nervous system disorders; Alzheimer's disease; cells transfected with Dna |
| 09/11/2003 | US20030170702 Methods for polysome distribution analysis of mRNA's |
| 09/11/2003 | US20030170699 Analyzing genes; sensitivity to hypotensive agents; diagnosing phenotypes; calibration |
| 09/11/2003 | US20030170694 Detection cell proliferation; design, screen drug libraries; forming antibiotic |
| 09/11/2003 | US20030170690 Immunocellular receptors related to neurological disorders and therapeutic uses thereof |
| 09/11/2003 | US20030170689 Determination of nucleic acid sequence pattern |
| 09/11/2003 | US20030170685 Canine hepatocyte growth factor |
| 09/11/2003 | US20030170682 Modified nucleic acid polymers and methods for their production |
| 09/11/2003 | US20030170681 Novel processes for non-linearly amplifying nucleic acids |
| 09/11/2003 | US20030170679 Hybrid growth hormone |
| 09/11/2003 | US20030170676 Mutation within the connexin 26 gene responsible for prelingual non-syndromic deafness and method of detection |
| 09/11/2003 | US20030170672 Using solution of fluorescent dyes; detecting signals |
| 09/11/2003 | US20030170669 Reducing side effects of blood transfusions; preferential adsorption |
| 09/11/2003 | US20030170668 Determination genotypes; genome screening; quantitative analysis |
| 09/11/2003 | US20030170664 Adsorption on solid surface; desorption by washing |
| 09/11/2003 | US20030170663 Nucleotide sequence of the Mycoplasma genitalium genome, fragments thereof, and uses thereof |
| 09/11/2003 | US20030170657 Protein; inducting antibodies; gene expression; diagnosis, vaccines |
| 09/11/2003 | US20030170656 Detection cell proliferation, cell differentiation; screen for gene expression |
| 09/11/2003 | US20030170655 Mus101 and homologue thereof |
| 09/11/2003 | US20030170653 Using genetic engineered enzyme |
| 09/11/2003 | US20030170652 Detection polymorphism of genes; testing using primer Dna; calibration |
| 09/11/2003 | US20030170651 Method of identifying a polymorphism in CYP2D6 |
| 09/11/2003 | US20030170650 Method of detecting target base sequence |
| 09/11/2003 | US20030170648 Autoimmune diseases; inflammatory bowel disease; multiple sclerosis; rheumatic diseases; modulate gene expression |
| 09/11/2003 | US20030170647 Nucleic acid encoding a retinoblastoma binding protein (RBP-7) and polymorphic markers associated with said nucleic acid |
| 09/11/2003 | US20030170646 Isolated bovine VDJ gene cassette comprising the nucleic acid sequence to develop chimeric immunoglobulin, for development of oral vaccines, vaccine vector, targeting specific tissues or organs |
| 09/11/2003 | US20030170645 Bardet-biedl susceptibility gene and uses thereof |
| 09/11/2003 | US20030170642 Identification of cellular targets for biologically active molecules |
| 09/11/2003 | US20030170641 Methods for screening for transdominant effector peptides and RNA molecules |
| 09/11/2003 | US20030170640 Immobilization; fluorination |
| 09/11/2003 | US20030170636 Controlling cell differentiation |
| 09/11/2003 | US20030170634 Polynucleotide encoding amylase; hydrolysis of starch |
| 09/11/2003 | US20030170633 High speed detection using nucleic acids; genetic engineering; transduction; obesity, antidiabetic agents; hypoglycemic agents |
| 09/11/2003 | US20030170632 IL-1 receptor accessory protein |
| 09/11/2003 | US20030170630 Proteins and nucleic acids encoding same |
| 09/11/2003 | US20030170629 Detection method and detection kit for PCR-amplified base sequences |
| 09/11/2003 | US20030170628 Forsenic analysis; medical diagnosis; chromosome markers |
| 09/11/2003 | US20030170622 Generation of specific binding partners binding to (poly)peptides encoded by genomic dna fragments or ests |
| 09/11/2003 | US20030170620 Gene controlling androgen |
| 09/11/2003 | US20030170617 Crude biological derivatives competent for nucleic acid detection |
| 09/11/2003 | US20030170616 Diagnosis using antibodies; genetic engineering |
| 09/11/2003 | US20030170615 Analyzing using monoclonal antibodies |
| 09/11/2003 | US20030170614 Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof |
| 09/11/2003 | US20030170612 Diagnostic assays for parvovirus B19 |
| 09/11/2003 | US20030170608 Determination activation of protein by quinine |
| 09/11/2003 | US20030170293 Thermotolerant phytase for animal feed |
| 09/11/2003 | US20030170274 Activation of HCV-specific T cells |
| 09/11/2003 | US20030170273 Type 1 interferon inducers, such as double-stranded RNA, in combination with antigen delivery systems and/or immunostimulatory molecules for enhancing the immune response of a coadministered antigen |
| 09/11/2003 | US20030170270 Nucleic acid encoding an infectious, nonpathogenic PCV1, which contains an immunogenic open reading frame gene of a pathogenic PCV2 in place of an ORF gene of the PCV1 nucleic acid molecule. |
| 09/11/2003 | US20030170268 Administering a fusion protein of a heat shock protein or immunostimulatory fragment and a human papilloma virus protein or an antigenic fragment; or a nucleic acid coding the fusion protein |
| 09/11/2003 | US20030170266 Complex of a paramyxovirus-derived negative-strand single-stranded RNA modified not to express an envelope protein of paramyxoviruses, and proteins that bind to it |
| 09/11/2003 | US20030170264 Stabilisation of plasmid inheritance in bacteria |
| 09/11/2003 | US20030170263 Expression system |
| 09/11/2003 | US20030170262 Immunogenic detoxified mutant E. coli LT-A toxin |
| 09/11/2003 | US20030170259 Chlamydia antigens and corresponding dna fragments and uses thereof |